Literature DB >> 1652287

Neurosarcoidosis without systemic sarcoidosis.

N Sommer1, M Weller, D Petersen, H Wiethölter, J Dichgans.   

Abstract

Neurosarcoidosis is a well-recognised complication of systemic sarcoidosis but diagnosis may be difficult if there is no clear evidence of an extracerebral manifestation of the disease. We present the case of a 42-year-old woman with clinical features characteristic of cerebral sarcoidosis including tetraparesis, diabetes insipidus, diencephalic hyperphagia, personality changes, and memory loss. Diagnosis was supported by cerebrospinal fluid (CSF) findings and magnetic resonance imaging (MRI): CSF showed mild lymphocytic pleocytosis, intrathecal production of IgG without oligoclonal bands, and a raised level of lysozyme. MRI revealed multiple contrast-enhanced granulomas at the base of the brain with partial involvement of diencephalic and mesencephalic structures and parts of the spinal cord. There was no evidence of systemic manifestation of sarcoidosis. Administration of corticosteroids led to improvement of the symptoms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652287     DOI: 10.1007/bf02279763

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  24 in total

1.  Spinal cord sarcoidosis: a new finding at MR imaging with Gd-DTPA enhancement.

Authors:  G M Nesbit; G M Miller; H L Baker; M J Ebersold; B W Scheithauer
Journal:  Radiology       Date:  1989-12       Impact factor: 11.105

2.  Cryptococcosis associated with sarcoidosis: CT and MR findings.

Authors:  K S Allen; M Glickstein; P H Arger; L Bilaniuk; D W Levy
Journal:  J Comput Assist Tomogr       Date:  1988 May-Jun       Impact factor: 1.826

3.  Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis.

Authors:  S J Borucki; B V Nguyen; C T Ladoulis; R R McKendall
Journal:  Arch Neurol       Date:  1989-03

4.  CSF angiotensin-converting enzyme in neurosarcoidosis.

Authors:  V Oksanen; F Fyhrquist; C Grönhagen-Riska; H Somer
Journal:  Lancet       Date:  1985-05-04       Impact factor: 79.321

Review 5.  [Neurosarcoidosis. Comparative analysis of the clinical profile based on 537 cases from the world literature up to 1963 and from 1976-1988].

Authors:  D Mende; R M Suchenwirth
Journal:  Fortschr Neurol Psychiatr       Date:  1990-01       Impact factor: 0.752

6.  Magnetic resonance imaging in central nervous system sarcoidosis.

Authors:  D H Miller; B E Kendall; S Barter; G Johnson; D G MacManus; S J Logsdail; I E Ormerod; W I McDonald
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

7.  Neurological manifestations of sarcoidosis.

Authors:  W C Wiederholt; R G Siekert
Journal:  Neurology       Date:  1965-12       Impact factor: 9.910

8.  Neurosarcoidosis: evaluation using computed tomography and magnetic resonance imaging.

Authors:  S D Cooper; M B Brady; J P Williams; K L Pilgreen; D L Harp; J R Weissmann
Journal:  J Comput Tomogr       Date:  1988-04

9.  Serum prolactin levels in eighty patients with sarcoidosis.

Authors:  K Nakao; K Noma; B Sato; S Yano; Y Yamamura; T Tachibana
Journal:  Eur J Clin Invest       Date:  1978-02       Impact factor: 4.686

10.  Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis.

Authors:  E C Lawrence; K P Brousseau; M B Berger; C C Kurman; L Marcon; D L Nelson
Journal:  Am Rev Respir Dis       Date:  1988-04
View more
  6 in total

Review 1.  [Differential diagnosis of chronic inflammatory diseases of the central nervous system. Cerebrospinal fluid diagnosis and immunological parameters].

Authors:  D Reske; H-F Petereit
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

Review 2.  The pituitary mass: diagnosis and management.

Authors:  Susan Sam; Mark E Molitch
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

Review 3.  Sarcoidosis of the spinal cord: literature review and report of eight cases.

Authors:  Samer Saleh; Chandan Saw; Kamel Marzouk; Om Sharma
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

4.  [Differential diagnosis of solitary neurosarcoidosis].

Authors:  J Schelhorn; U Smesny; C Fitzek; M Brodhun; O W Witte; C Terborg
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

Review 5.  The challenge of profound hypoglycorrhachia: two cases of sarcoidosis and review of the literature.

Authors:  Harini Sarva; Rachel Chapman; Eghosa Omoregie; Charles Abrams
Journal:  Clin Rheumatol       Date:  2011-08-26       Impact factor: 2.980

Review 6.  Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.

Authors:  N Sommer; A Melms; M Weller; J Dichgans
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.